Effects of profit‐reducing policies on firm survival, financial performance, and new drug introductions in the research‐based pharmaceutical industry
We introduce a computational model of the evolution of a value‐maximizing research‐based
pharmaceutical firm and parameterize it using estimates of R&D costs, profit distributions …
pharmaceutical firm and parameterize it using estimates of R&D costs, profit distributions …
Effects of profit-reducing policies on firm survival, financial performance, and new drug introductions in the research-based pharmaceutical industry
D Filson, N Masia - Managerial and Decision Economics, 2007 - ideas.repec.org
We introduce a computational model of the evolution of a value-maximizing research-based
pharmaceutical firm and parameterize it using estimates of R&D costs, profit distributions …
pharmaceutical firm and parameterize it using estimates of R&D costs, profit distributions …
Effects of profit-reducing policies on firm survival, financial performance, and new drug introductions in the research-based pharmaceutical industry
D Filson, N Masia - Managerial and Decision Economics, 2007 - econpapers.repec.org
We introduce a computational model of the evolution of a value-maximizing research-based
pharmaceutical firm and parameterize it using estimates of R&D costs, profit distributions …
pharmaceutical firm and parameterize it using estimates of R&D costs, profit distributions …
Effects of Profit-Reducing Policies on Firm Survival, Financial Performance, and New Drug Introductions in the Research-Based Pharmaceutical Industry [with …
D Filson, N Masia, J Golec - Managerial and Decision Economics, 2007 - JSTOR
We introduce a computational model of the evolution of a value-maximizing research-based
pharmaceutical firm and parameterize it using estimates of R&D costs, profit distributions …
pharmaceutical firm and parameterize it using estimates of R&D costs, profit distributions …
Effects of profit-reducing policies on firm survival, financial performance, and new drug introductions in the research-based pharmaceutical industry.
D Filson, N Masia - Managerial & Decision Economics, 2007 - search.ebscohost.com
We introduce a computational model of the evolution of a value-maximizing research-based
pharmaceutical firm and parameterize it using estimates of R& D costs, profit …
pharmaceutical firm and parameterize it using estimates of R& D costs, profit …